Concepts (301)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 38 | 2020 | 5866 | 1.580 |
Why?
|
| Sexual and Gender Minorities | 5 | 2021 | 77 | 1.550 |
Why?
|
| Erectile Dysfunction | 9 | 2016 | 239 | 1.340 |
Why?
|
| Homosexuality, Male | 6 | 2021 | 75 | 1.270 |
Why?
|
| Quality of Life | 24 | 2021 | 4761 | 1.200 |
Why?
|
| Urinary Bladder Neoplasms | 10 | 2021 | 2431 | 1.140 |
Why?
|
| United States Department of Veterans Affairs | 3 | 2018 | 663 | 0.940 |
Why?
|
| Sexual Dysfunction, Physiological | 5 | 2016 | 136 | 0.890 |
Why?
|
| Health Personnel | 3 | 2020 | 652 | 0.820 |
Why?
|
| Sexual Partners | 5 | 2016 | 103 | 0.800 |
Why?
|
| Patient Education as Topic | 7 | 2016 | 745 | 0.790 |
Why?
|
| Nurses | 1 | 2021 | 85 | 0.700 |
Why?
|
| Health Status | 6 | 2016 | 631 | 0.700 |
Why?
|
| Bisexuality | 3 | 2016 | 21 | 0.680 |
Why?
|
| Survivorship | 1 | 2020 | 116 | 0.680 |
Why?
|
| Internship, Nonmedical | 1 | 2018 | 2 | 0.650 |
Why?
|
| Patient Care Planning | 1 | 2020 | 303 | 0.620 |
Why?
|
| Sexual Dysfunctions, Psychological | 4 | 2013 | 69 | 0.610 |
Why?
|
| Physician Assistants | 1 | 2018 | 76 | 0.590 |
Why?
|
| Suburban Population | 1 | 2017 | 4 | 0.580 |
Why?
|
| Health Facilities | 1 | 2018 | 75 | 0.580 |
Why?
|
| Prostatectomy | 14 | 2016 | 1003 | 0.550 |
Why?
|
| Veterans | 6 | 2018 | 1737 | 0.540 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2020 | 600 | 0.540 |
Why?
|
| Watchful Waiting | 3 | 2015 | 293 | 0.530 |
Why?
|
| Cancer Survivors | 2 | 2020 | 742 | 0.530 |
Why?
|
| Interpersonal Relations | 7 | 2018 | 278 | 0.520 |
Why?
|
| Anxiety | 7 | 2018 | 1240 | 0.510 |
Why?
|
| Urban Population | 1 | 2017 | 280 | 0.510 |
Why?
|
| Primary Health Care | 3 | 2018 | 831 | 0.510 |
Why?
|
| Rural Population | 1 | 2017 | 292 | 0.480 |
Why?
|
| Sexology | 1 | 2014 | 3 | 0.480 |
Why?
|
| Perception | 2 | 2012 | 349 | 0.430 |
Why?
|
| Culture | 1 | 2012 | 104 | 0.390 |
Why?
|
| Health Surveys | 1 | 2012 | 400 | 0.360 |
Why?
|
| Male | 65 | 2024 | 128315 | 0.350 |
Why?
|
| Cystectomy | 2 | 2016 | 635 | 0.340 |
Why?
|
| Urinary Diversion | 2 | 2016 | 86 | 0.340 |
Why?
|
| Decision Making | 3 | 2011 | 1252 | 0.320 |
Why?
|
| Surveys and Questionnaires | 14 | 2018 | 5923 | 0.320 |
Why?
|
| Social Support | 5 | 2016 | 590 | 0.310 |
Why?
|
| Mental Disorders | 4 | 2012 | 882 | 0.310 |
Why?
|
| Needs Assessment | 2 | 2011 | 238 | 0.310 |
Why?
|
| Health Behavior | 1 | 2012 | 601 | 0.290 |
Why?
|
| Life Style | 3 | 2012 | 618 | 0.290 |
Why?
|
| Patient Admission | 1 | 2009 | 231 | 0.290 |
Why?
|
| Depression | 9 | 2018 | 1730 | 0.280 |
Why?
|
| Self Concept | 2 | 2016 | 198 | 0.280 |
Why?
|
| Middle Aged | 41 | 2020 | 90352 | 0.280 |
Why?
|
| Humans | 72 | 2024 | 270740 | 0.260 |
Why?
|
| Resistance Training | 1 | 2024 | 38 | 0.230 |
Why?
|
| Sexual Behavior | 6 | 2021 | 313 | 0.220 |
Why?
|
| Patient Discharge | 1 | 2009 | 698 | 0.220 |
Why?
|
| Aged | 36 | 2020 | 73333 | 0.220 |
Why?
|
| Muscle Strength | 1 | 2024 | 102 | 0.220 |
Why?
|
| Evidence-Based Medicine | 1 | 2008 | 1034 | 0.220 |
Why?
|
| Impotence, Vasculogenic | 1 | 2003 | 10 | 0.220 |
Why?
|
| Mental Health | 1 | 2006 | 416 | 0.210 |
Why?
|
| Iraq War, 2003-2011 | 2 | 2013 | 117 | 0.210 |
Why?
|
| Afghan Campaign 2001- | 2 | 2013 | 122 | 0.210 |
Why?
|
| Substance-Related Disorders | 2 | 2021 | 547 | 0.210 |
Why?
|
| Adaptation, Psychological | 5 | 2016 | 787 | 0.190 |
Why?
|
| Diabetes Mellitus | 3 | 2006 | 1024 | 0.190 |
Why?
|
| Fear | 3 | 2015 | 253 | 0.190 |
Why?
|
| Prostate-Specific Antigen | 7 | 2008 | 1029 | 0.190 |
Why?
|
| Social Workers | 1 | 2021 | 5 | 0.190 |
Why?
|
| Self-Help Groups | 2 | 2013 | 36 | 0.190 |
Why?
|
| Sex Offenses | 1 | 2021 | 49 | 0.180 |
Why?
|
| Health Care Surveys | 2 | 2020 | 418 | 0.180 |
Why?
|
| Patient Satisfaction | 4 | 2016 | 917 | 0.180 |
Why?
|
| Insurance Coverage | 3 | 2008 | 275 | 0.180 |
Why?
|
| United States | 11 | 2018 | 15861 | 0.160 |
Why?
|
| Focus Groups | 1 | 2020 | 285 | 0.160 |
Why?
|
| Severity of Illness Index | 2 | 2006 | 4372 | 0.160 |
Why?
|
| Risk-Taking | 2 | 2012 | 131 | 0.160 |
Why?
|
| Registries | 9 | 2007 | 2211 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 5776 | 0.150 |
Why?
|
| Program Evaluation | 2 | 2018 | 603 | 0.150 |
Why?
|
| Homosexuality | 2 | 2016 | 30 | 0.150 |
Why?
|
| Counseling | 2 | 2011 | 381 | 0.150 |
Why?
|
| Personality Inventory | 2 | 2012 | 197 | 0.150 |
Why?
|
| Faculty | 1 | 2018 | 132 | 0.150 |
Why?
|
| Patient-Centered Care | 1 | 2021 | 318 | 0.140 |
Why?
|
| Health Services Needs and Demand | 2 | 2016 | 247 | 0.140 |
Why?
|
| Cost of Illness | 2 | 2013 | 505 | 0.140 |
Why?
|
| Muscle, Skeletal | 1 | 2024 | 1286 | 0.140 |
Why?
|
| Tobacco Use | 1 | 2017 | 63 | 0.140 |
Why?
|
| Qualitative Research | 1 | 2020 | 642 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 8 | 2007 | 10400 | 0.140 |
Why?
|
| Longitudinal Studies | 9 | 2007 | 2057 | 0.130 |
Why?
|
| Mentors | 1 | 2018 | 210 | 0.130 |
Why?
|
| Heterosexuality | 1 | 2016 | 14 | 0.130 |
Why?
|
| Body Mass Index | 3 | 2017 | 2232 | 0.130 |
Why?
|
| Leadership | 1 | 2018 | 271 | 0.130 |
Why?
|
| Androgen Antagonists | 2 | 2010 | 420 | 0.130 |
Why?
|
| Travel | 1 | 2017 | 203 | 0.130 |
Why?
|
| Veterans Health | 1 | 2017 | 174 | 0.130 |
Why?
|
| Alcoholism | 1 | 2018 | 332 | 0.130 |
Why?
|
| Socioeconomic Factors | 4 | 2007 | 1267 | 0.130 |
Why?
|
| Adult | 18 | 2024 | 82040 | 0.130 |
Why?
|
| Patient Care Team | 1 | 2021 | 823 | 0.120 |
Why?
|
| Object Attachment | 1 | 2015 | 52 | 0.120 |
Why?
|
| Follow-Up Studies | 10 | 2014 | 15218 | 0.120 |
Why?
|
| Survivors | 3 | 2016 | 1021 | 0.120 |
Why?
|
| Uncertainty | 3 | 2015 | 328 | 0.120 |
Why?
|
| Neoplasm Staging | 6 | 2013 | 14012 | 0.120 |
Why?
|
| Psychometrics | 4 | 2012 | 973 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2013 | 1235 | 0.120 |
Why?
|
| Cystoscopy | 1 | 2014 | 92 | 0.120 |
Why?
|
| Feasibility Studies | 1 | 2020 | 2353 | 0.120 |
Why?
|
| Female | 15 | 2020 | 148940 | 0.120 |
Why?
|
| Health Care Costs | 2 | 2011 | 699 | 0.120 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 4492 | 0.110 |
Why?
|
| Reproducibility of Results | 6 | 2012 | 6177 | 0.110 |
Why?
|
| Libido | 2 | 2010 | 37 | 0.110 |
Why?
|
| Unsafe Sex | 1 | 2012 | 21 | 0.110 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2012 | 21 | 0.110 |
Why?
|
| Stress, Psychological | 3 | 2016 | 1043 | 0.100 |
Why?
|
| Internet | 1 | 2017 | 690 | 0.100 |
Why?
|
| Attitude to Health | 3 | 2012 | 434 | 0.100 |
Why?
|
| Epidemiologic Methods | 2 | 2010 | 254 | 0.100 |
Why?
|
| Self Efficacy | 3 | 2015 | 299 | 0.100 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2010 | 347 | 0.100 |
Why?
|
| Disease Management | 2 | 2014 | 1090 | 0.100 |
Why?
|
| Kidney Pelvis | 1 | 2012 | 114 | 0.090 |
Why?
|
| Time Factors | 6 | 2017 | 13006 | 0.090 |
Why?
|
| Quality Improvement | 1 | 2018 | 914 | 0.090 |
Why?
|
| Documentation | 1 | 2013 | 213 | 0.090 |
Why?
|
| Pilot Projects | 3 | 2012 | 2828 | 0.090 |
Why?
|
| Hospitalization | 3 | 2009 | 2167 | 0.090 |
Why?
|
| Databases, Factual | 3 | 2007 | 2250 | 0.090 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 831 | 0.090 |
Why?
|
| Health Promotion | 1 | 2014 | 510 | 0.090 |
Why?
|
| Clinical Competence | 1 | 2018 | 1325 | 0.090 |
Why?
|
| Patient Compliance | 1 | 2014 | 676 | 0.090 |
Why?
|
| Health Resources | 1 | 2011 | 171 | 0.090 |
Why?
|
| Mental Health Services | 2 | 2013 | 258 | 0.090 |
Why?
|
| Congresses as Topic | 1 | 2012 | 299 | 0.090 |
Why?
|
| Penile Erection | 1 | 2010 | 88 | 0.080 |
Why?
|
| Ureteral Neoplasms | 1 | 2012 | 238 | 0.080 |
Why?
|
| Proportional Hazards Models | 6 | 2012 | 5101 | 0.080 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2012 | 905 | 0.080 |
Why?
|
| HIV Infections | 3 | 2012 | 2154 | 0.080 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2016 | 999 | 0.080 |
Why?
|
| Health Policy | 2 | 2014 | 278 | 0.080 |
Why?
|
| Private Sector | 1 | 2009 | 31 | 0.080 |
Why?
|
| Sexuality | 1 | 2009 | 38 | 0.080 |
Why?
|
| Case Management | 1 | 2009 | 37 | 0.080 |
Why?
|
| Anxiety Disorders | 1 | 2015 | 725 | 0.080 |
Why?
|
| Smoking | 2 | 2014 | 2555 | 0.080 |
Why?
|
| Group Processes | 1 | 2009 | 56 | 0.080 |
Why?
|
| Psychology | 1 | 2009 | 83 | 0.080 |
Why?
|
| Smoking Cessation | 1 | 2014 | 776 | 0.080 |
Why?
|
| Models, Psychological | 1 | 2009 | 179 | 0.070 |
Why?
|
| Family | 1 | 2012 | 783 | 0.070 |
Why?
|
| Medication Adherence | 1 | 2012 | 513 | 0.070 |
Why?
|
| Goals | 1 | 2009 | 187 | 0.070 |
Why?
|
| Coitus | 1 | 2006 | 24 | 0.070 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2006 | 44 | 0.070 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2009 | 165 | 0.070 |
Why?
|
| Cisplatin | 1 | 2013 | 2497 | 0.070 |
Why?
|
| Sexually Transmitted Diseases | 3 | 2013 | 105 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2009 | 647 | 0.070 |
Why?
|
| Insurance, Health | 1 | 2008 | 261 | 0.070 |
Why?
|
| North America | 1 | 2006 | 338 | 0.060 |
Why?
|
| Age Factors | 5 | 2016 | 5457 | 0.060 |
Why?
|
| Neoplasms | 1 | 2012 | 15927 | 0.060 |
Why?
|
| Orchiectomy | 1 | 2006 | 211 | 0.060 |
Why?
|
| Psychiatry | 1 | 2009 | 275 | 0.060 |
Why?
|
| Primary Prevention | 1 | 2006 | 231 | 0.060 |
Why?
|
| Sex Factors | 3 | 2016 | 2184 | 0.060 |
Why?
|
| Complementary Therapies | 1 | 2005 | 120 | 0.060 |
Why?
|
| Health Services | 1 | 2005 | 100 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2015 | 13414 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2009 | 602 | 0.060 |
Why?
|
| Demography | 1 | 2005 | 433 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2009 | 436 | 0.050 |
Why?
|
| Obesity | 2 | 2006 | 2904 | 0.050 |
Why?
|
| Social Values | 1 | 1993 | 56 | 0.050 |
Why?
|
| Spouses | 2 | 2016 | 140 | 0.050 |
Why?
|
| Treatment Outcome | 6 | 2013 | 33737 | 0.050 |
Why?
|
| Prostate | 3 | 2020 | 1089 | 0.050 |
Why?
|
| Cohort Studies | 5 | 2008 | 9470 | 0.050 |
Why?
|
| Length of Stay | 1 | 2009 | 2007 | 0.050 |
Why?
|
| Research Design | 1 | 2009 | 1569 | 0.050 |
Why?
|
| Risk Factors | 8 | 2015 | 17888 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2003 | 300 | 0.050 |
Why?
|
| Disease-Free Survival | 4 | 2006 | 10265 | 0.050 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2006 | 841 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1993 | 368 | 0.050 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2006 | 2271 | 0.040 |
Why?
|
| Regression Analysis | 3 | 2012 | 1571 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2009 | 2400 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2013 | 39890 | 0.040 |
Why?
|
| Prognosis | 5 | 2013 | 22505 | 0.040 |
Why?
|
| Homeostasis | 1 | 2024 | 925 | 0.040 |
Why?
|
| Lymph Node Excision | 1 | 2006 | 2062 | 0.040 |
Why?
|
| Aged, 80 and over | 6 | 2016 | 30998 | 0.040 |
Why?
|
| Multivariate Analysis | 4 | 2008 | 4328 | 0.040 |
Why?
|
| Kidney Neoplasms | 1 | 2012 | 3108 | 0.040 |
Why?
|
| Resilience, Psychological | 1 | 2018 | 71 | 0.040 |
Why?
|
| Adenocarcinoma | 2 | 2006 | 7914 | 0.040 |
Why?
|
| Age Distribution | 1 | 2018 | 727 | 0.030 |
Why?
|
| Texas | 2 | 2021 | 6449 | 0.030 |
Why?
|
| Social Class | 2 | 2008 | 324 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2004 | 1302 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 2016 | 251 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2012 | 2315 | 0.030 |
Why?
|
| Self Care | 1 | 2016 | 246 | 0.030 |
Why?
|
| Young Adult | 3 | 2024 | 22251 | 0.030 |
Why?
|
| Risk Assessment | 3 | 2013 | 6764 | 0.030 |
Why?
|
| California | 2 | 2005 | 212 | 0.030 |
Why?
|
| Comorbidity | 2 | 2012 | 2394 | 0.030 |
Why?
|
| Health Education | 1 | 1996 | 303 | 0.030 |
Why?
|
| Child Abuse, Sexual | 1 | 2013 | 36 | 0.030 |
Why?
|
| Disease Progression | 2 | 2015 | 6867 | 0.030 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2012 | 71 | 0.030 |
Why?
|
| Infertility | 1 | 2013 | 105 | 0.020 |
Why?
|
| Long-Term Care | 1 | 2011 | 85 | 0.020 |
Why?
|
| Violence | 1 | 2012 | 126 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 353 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2013 | 329 | 0.020 |
Why?
|
| Feminization | 1 | 2010 | 3 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 4960 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 14617 | 0.020 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2011 | 218 | 0.020 |
Why?
|
| Hospitals, Veterans | 1 | 2013 | 371 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2012 | 521 | 0.020 |
Why?
|
| Canada | 1 | 2011 | 440 | 0.020 |
Why?
|
| Emotions | 2 | 2005 | 560 | 0.020 |
Why?
|
| Biopsy, Needle | 2 | 2005 | 1379 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2011 | 206 | 0.020 |
Why?
|
| Informatics | 1 | 2009 | 19 | 0.020 |
Why?
|
| Health Literacy | 1 | 2010 | 117 | 0.020 |
Why?
|
| Medical Laboratory Science | 1 | 2009 | 23 | 0.020 |
Why?
|
| Parents | 1 | 1996 | 1082 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2016 | 4000 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2012 | 1016 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 4048 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 681 | 0.020 |
Why?
|
| Asthma | 1 | 1996 | 895 | 0.020 |
Why?
|
| SEER Program | 1 | 2012 | 1047 | 0.020 |
Why?
|
| Income | 1 | 2008 | 235 | 0.020 |
Why?
|
| Sex Education | 1 | 2006 | 24 | 0.020 |
Why?
|
| Inpatients | 1 | 2012 | 683 | 0.020 |
Why?
|
| Sleep Wake Disorders | 1 | 2010 | 372 | 0.020 |
Why?
|
| Consensus | 1 | 2011 | 1106 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 681 | 0.020 |
Why?
|
| Finasteride | 1 | 2006 | 29 | 0.020 |
Why?
|
| Diethylstilbestrol | 1 | 2006 | 165 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2005 | 10708 | 0.020 |
Why?
|
| Educational Status | 1 | 2007 | 392 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2007 | 310 | 0.020 |
Why?
|
| Survival Rate | 2 | 2012 | 12541 | 0.020 |
Why?
|
| Retreatment | 1 | 2007 | 448 | 0.020 |
Why?
|
| Life Tables | 1 | 2005 | 120 | 0.020 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2012 | 645 | 0.020 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2006 | 169 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 3444 | 0.020 |
Why?
|
| Health Maintenance Organizations | 1 | 2005 | 27 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 2650 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2005 | 218 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 9039 | 0.010 |
Why?
|
| Cognition | 1 | 2010 | 959 | 0.010 |
Why?
|
| Pelvis | 1 | 2006 | 381 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 1312 | 0.010 |
Why?
|
| Urinary Tract | 1 | 2005 | 86 | 0.010 |
Why?
|
| Fatigue | 1 | 2010 | 1275 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 5162 | 0.010 |
Why?
|
| Ejaculation | 1 | 2003 | 26 | 0.010 |
Why?
|
| Condoms | 1 | 1993 | 50 | 0.010 |
Why?
|
| Social Behavior | 1 | 2005 | 310 | 0.010 |
Why?
|
| Sick Role | 1 | 2003 | 72 | 0.010 |
Why?
|
| AIDS Serodiagnosis | 1 | 1993 | 57 | 0.010 |
Why?
|
| Exercise | 1 | 2010 | 1184 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2016 | 5231 | 0.010 |
Why?
|
| Penile Prosthesis | 1 | 2003 | 41 | 0.010 |
Why?
|
| Data Collection | 1 | 2005 | 608 | 0.010 |
Why?
|
| HIV Seropositivity | 1 | 1993 | 155 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2005 | 539 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6256 | 0.010 |
Why?
|
| Incidence | 1 | 2012 | 5824 | 0.010 |
Why?
|
| Brachytherapy | 1 | 2008 | 1005 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2016 | 5681 | 0.010 |
Why?
|
| Risk | 1 | 2005 | 1939 | 0.010 |
Why?
|
| Age of Onset | 1 | 2003 | 853 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2008 | 1857 | 0.010 |
Why?
|
| Intestines | 1 | 2005 | 736 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2007 | 855 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2006 | 1320 | 0.010 |
Why?
|
| Probability | 1 | 2002 | 886 | 0.010 |
Why?
|
| Recurrence | 1 | 2008 | 4878 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 1942 | 0.010 |
Why?
|
| Adolescent | 2 | 2012 | 32767 | 0.010 |
Why?
|
| Pain | 1 | 2005 | 1694 | 0.010 |
Why?
|
| Child | 2 | 2013 | 30559 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1996 | 749 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 1996 | 306 | 0.010 |
Why?
|
| Odds Ratio | 1 | 1996 | 2311 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 61956 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1996 | 17061 | 0.000 |
Why?
|